Results 101 to 110 of about 25,460 (223)
Botulinum toxin injection: a review of injection principles and protocols
International Brazilian Journal of Urology, 2007 Despite the favorable outcomes seen using botulinum toxin (BTX) for voiding dysfunction using BTX, a standardized technique and protocol for toxin injection is not defined. We reviewed the current literature on intravesical BTX injection for DO (detrusor
David E. Rapp +2 more
doaj +1 more source
Botulinum toxin therapy for nonneurogenic overactive bladder: first experience
Acta Medica Lituanica, 2011 The paper presents early experience in the treatment of 20 patients with botulinum toxin injections into the detrusor muscle for the treatment of non-neurogenic overactive bladder (OAB) resistant to anticholinergic drugs. Background.
Aušra ČERNIAUSKIENĖ +1 more
doaj +1 more source
Neurourology and Urodynamics, Volume 45, Issue 8, Page 1556-1561, November 2026.ABSTRACT Purpose Detrusor underactivity (DU) is a significant cause of female lower urinary tract symptoms. We aimed to externally validate a non‐invasive prediction model using age and voided volume (VV) in a tertiary center cohort. Methods This retrospective study included 450 consecutive women who underwent uroflowmetry and subsequently multichannel
Netanel Levin +7 more
wiley +1 more source
Neurourology and Urodynamics, Volume 45, Issue 8, Page 1671-1677, November 2026.ABSTRACT Introduction Sacral neuromodulation (SNM) is a therapeutic option offered to patients with idiopathic overactive bladder (OAB) or non‐obstructive urinary retention, as an alternative treatment for refractory medical management. It allows for electrical stimulation of inhibitory circuits that modulate the micturition reflex and improve lower ...
Carly Fiorido +10 more
wiley +1 more source
LUTS: Lower Urinary Tract Symptoms, Volume 18, Issue 6, November 2026.ABSTRACT Objectives Drug treatment for overactive bladder (OAB) is changing, with an increasing share of β3‐adrenoceptor agonists relative to anticholinergics, but it is not known how far this change has progressed in older people, who are most vulnerable to the risks of anticholinergics.
Toshikazu Koike +9 more
wiley +1 more source
Overactive bladder, differential diagnosis, and clinical utility of fesoterodine
, 2012 Jean-Jacques WyndaeleDepartment of Urology, Antwerp University, Antwerp, BelgiumAbstract: Overactive bladder is a symptom syndrome with urgency, frequency and, in many cases, nocturia. Urge incontinence is not present in all.
Wyndaele J-J
core
Adherence junctions and cadherin-11 in normal and overactive human detrusor smooth muscle cells
, 2011 Item does not contain fulltextPURPOSE: We investigated whether analysis of adherence junctions in human detrusor could be used as a diagnostic tool to determine detrusor overactivity.
Kamiel A.J. Kuijpers +7 more
core +1 more source
The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor
, 2006 Purpose: We determined the effect of detrusor injection of botulinum-A toxin in a cohort of children with therapy resistant nonneurogenic detrusor overactivity. This prospective study included therapy resistant children with overactive bladder.
Vande Walle, Johan +6 more
core +1 more source
Detrusor after-contraction on ambulatory urodynamics in symptomatic women.
, 2015 ObjectivesTo investigate the association between detrusor after-contraction and urodynamic parameters in a cohort of patients undergoing urodynamic studies by ambulatory monitoring.MethodsAll symptomatic adult female patients with non-neurogenic lower ...
Veeratterapillay, R +5 more
core +1 more source
The role of P1 receptors in regulating detrusor contraction: their relevance in the overactive bladder [PDF]
, 2010 Bladder motor nerves co-release acetylcholine and ATP. ATP is degraded to adenosine at the neuro-muscular junction where it is hypothesized to modulate detrusor contraction by acting on Pl receptors.
Hussain, Mahreen
core +1 more source